- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
eyeforpharma Awards 2019 Announced
eyeforpharma announced the date for their awards event for 2019. The eyeforpharma awards focus exclusively on value for patients and HCPs to support the best work in the industry.
The awards will be celebrating health entrepreneurs, valuable collaborations, patient advocates, and champions. The patient awards will be judged by a group of patients for the patients. The nominations are now open for the 13 categories, and the ceremony will take place on December 11th in Philadelphia.
Nominations open 29th April, closing 9th August, with Finalists announced by eyeforpharma on 5th September. Finalists will be selected by a judging panel of industry experts.
For more information, visit here or contact Liz Swift at eswift@eyeforpharma.com.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
